- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by GTC Biotherapeutics
Total 907 results
-
Cancer Research UKAleta BioTherapeuticsRecruitingLymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-CellUnited Kingdom
-
Affimed GmbHArtiva Biotherapeutics, Inc.RecruitingPeripheral T Cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaUnited States
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RecruitingRelapsed/Refractory Acute Myeloid LeukemiaChina
-
EpimAb Biotherapeutics (Suzhou)Co., Ltd.RecruitingAdvanced/Metastatic Solid Tumors | Relapse/Refractory LymphomaChina, Australia
-
Shanghai EpimAb Biotherapeutics Co., Ltd.RecruitingRelapsed or Refractory Multiple MyelomaChina, Australia
-
Fore BiotherapeuticsRabin Medical CenterCompleted
-
University of PennsylvaniaNorthwest BiotherapeuticsWithdrawnOvarian Cancer | Primary Peritoneal CancerUnited States
-
GTxWithdrawnER+ and AR+ Breast CancerUnited States
-
GTxTerminatedProstate CancerUnited States
-
GTxCompletedPreneoplastic Conditions | Prostatic Intraepithelial NeoplasiaUnited States, Argentina, Canada
-
GTxCompletedProstate CancerUnited States
-
GTxTerminatedTriple Negative Breast CancerUnited States
-
GTxCompletedProstate Cancer | Osteoporosis | FracturesUnited States, Mexico
-
GTxWithdrawnStress Urinary IncontinenceUnited States
-
GTxTerminatedProstate CancerUnited States
-
GTxCompletedStress Urinary IncontinenceUnited States
-
GTxCompletedStress Urinary IncontinenceUnited States
-
GTxCompletedNon-Small Cell Lung Cancer | Muscle WastingUnited States
-
GTxCompletedNon Small Cell Lung Cancer | Muscle WastingUnited States
-
GTxTerminatedMetastatic Breast CancerUnited States
-
GTxWithdrawnStress Urinary IncontinenceUnited States
-
GTxCompletedER+ and AR+ Breast CancerUnited States
-
GTxCompletedProstatic Intraepithelial NeoplasiaUnited States
-
Noveome Biotherapeutics, formerly StemnionIQVIA BiotechTerminatedPersistent Corneal Epithelial DefectUnited States
-
Noveome Biotherapeutics, formerly StemnionIQVIA BiotechCompletedCytokine Release SyndromeUnited States
-
Bridge Biotherapeutics, Inc.KCRN Research, LLCCompletedUlcerative ColitisUnited States
-
Loma Linda UniversityNitric BioTherapeutics, IncTerminatedChronic Ulcer of Lower ExtremityUnited States
-
Steminent US, Inc.Not yet recruitingSpinocerebellar Ataxias
-
AdventHealth Translational Research InstituteBioTherapeutics Inc.RecruitingPre DiabetesUnited States
-
Atara BiotherapeuticsMerck Sharp & Dohme LLCTerminatedNasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Epstein-Barr Virus Infections | Epstein-Barr Viraemia | Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)United States
-
Prometic Biotherapeutics, Inc.Atlantic Research GroupCompletedPrimary ImmunodeficiencyUnited States
-
Stealth BioTherapeutics Inc.ICON Clinical ResearchCompletedReperfusion Injury | STEMIUnited States, Hungary, Germany, Poland
-
Bridge Biotherapeutics, Inc.KCRN Research, LLCCompletedIdiopathic Pulmonary FibrosisUnited States
-
Shanghai EpimAb Biotherapeutics Co., Ltd.CovanceRecruitingNeoplasms | Neoplasm Metastasis | Non-Small-Cell Lung CancerUnited States, China
-
Bolt Biotherapeutics, Inc.Bristol-Myers SquibbActive, not recruitingHER2-positive Breast Cancer | HER2-positive Colorectal Cancer | HER2-positive Solid Tumors | HER2-positive Gastroesophageal Cancer | HER2-positive Endometrial CancerFrance, United States, Spain, Korea, Republic of, Italy
-
Bolt Biotherapeutics, Inc.Hoffmann-La RocheActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerSpain, United States, Italy
-
Bridge Biotherapeutics, Inc.KCRN Research, LLCTerminated
-
Aeglea BiotherapeuticsMerck Sharp & Dohme LLCCompletedSmall-cell Lung CancerUnited States, Puerto Rico
-
Bridge Biotherapeutics, Inc.KCRN Research, LLCCompletedHealthy ParticipantsUnited States
-
Bridge Biotherapeutics, Inc.KCRN Research, LLCCompletedHealthy ParticipantsUnited States
-
CardioVascular BioTherapeutics, Inc.Warren General HospitalCompletedDiabetes | Venous Stasis Ulcers | Chronic WoundsUnited States
-
PTC TherapeuticsRecruitingA Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)Huntington DiseaseUnited States, Austria, Spain, United Kingdom, Australia, France, Germany, Netherlands, Italy, New Zealand, Canada
-
PTC TherapeuticsEnrolling by invitationInherited Mitochondrial DiseaseUnited States, France, Spain, United Kingdom, Italy, Poland, Japan
-
PTC TherapeuticsActive, not recruitingAmyotrophic Lateral SclerosisUnited States, Belgium, Spain, Australia, Germany, Italy, Czechia, France, Netherlands, Japan, Poland, Argentina, Sweden
-
PTC TherapeuticsCompletedNonsene Mutation Duchenne Muscular DystrophyUnited States
-
PTC TherapeuticsCompletedMitochondrial Diseases | Drug Resistant Epilepsy | Leigh Disease | Leigh Syndrome | Mitochondrial Encephalopathy (MELAS) | Pontocerebellar Hypoplasia Type 6 (PCH6) | Alpers Disease | Alpers SyndromeUnited States, Spain, United Kingdom, Canada, France, Italy, Poland, Sweden, Japan
-
PTC TherapeuticsNo longer available
-
PTC TherapeuticsCompletedBH4 Deficiency | HyperphenylalaninemiaUnited States